ISAP Researchers' Profiles
Jeffrey J. Annon, M.A.
Jeffrey J. Annon, M.A., MIS/M., is currently facilitating the ISAP Research Training for International Scholars. The goal for this year-long, non-degree training experience is to provide information to visiting scholars on addiction research as well as familiarize them with information on foundational knowledge on evidence-based prevention and treatment practices currently in use in the United States and other parts of the world. This training is designed for international MDs and Ph.D. who are interested in developing addiction research careers. Mr. Annon is also coordinating the Vietnam HIV Addiction Technology Transfer Center Network, a SAMHSA project training addiction professionals in Vietnam. Mr. Annon was recently the Research Coordinator for the Accelerated Development of Additive Pharmacotherapy Treatment Project (ADAPT) at the ISAP Outpatient Clinical Research Center. He has been involved in several CTN studies including the Cocaine Use Reduction with Buprenorphine Study (CURB), START Follow up and the HOPE project (CTN 49, CTN 50). He has done data analysis for the Evaluation, Training and Technical Assistance for Substance Use Disorder Services Integration project. He was past director of the Data Management Center and was a part of the UCLA Methamphetamine Treatment Project, which compared treatments for methamphetamine abuse in five cities in the United States. He was also the Project Director for the UCLA LAAM project, which compared methadone and levo-alpha-acetyl methadol (LAAM) treatment of heroin addicts in Los Angeles. Mr. Annon has been with the UCLA Drug Abuse Research Center (which, with other entities, became ISAP in 1999) since 1990, working on various research projects.
Education and Training
- University of Hawaii at Manoa, B.A., 1980, Psychology
- California State University at Long Beach, M.A., 1993, Psychology
- University of Phoenix, MIS/M, 2006, Information Systems Management
UCLA Integrated Substance Abuse Programs
1640 S. Sepulveda Blvd., Suite 120
Los Angeles, CA 90025
Crèvecoeur-MacPhail, D., Ransom, L., Myers, A.C., Annon, J.J., Diep, N., Gonzales, R., Rawson, R.A., Viernes, J., Jr., Sugita, W., & Barger, J. (2010). Inside the black box: Measuring addiction treatment services and their relation to outcomes. Journal of Psychoactive Drugs, SARC Supplement 6, 269-276.
Ling, W., Hillhouse, M., Domier, C., Doraimani, G., Hunter, J., Thomas, C., Jenkins, J., Hasson, A., Annon, J., Saxon, A., Selzer, J., Boverman, J. & Bilangi, R. (2009). Buprenorphine tapering schedule and illicit opioid use. Addiction, 104, 256-265.
Conner, B.T., Anglin, M.D., Annon, J, & Longshore, D. (2009). Effect of Religiousity and Spirituality on Drug Treatment. Behavior. Journal of Behavioral Health Services and Research, Special Issue, 36:2 189-198.
Anglin, M.D., Conner, B.T., Annon, J., & Longshore, D. (2009). Longitudinal Effects of LAAM and Methadone Maintenance on Heroin Addict Behavior. Journal of Behavioral Health Services and Research, Special Issue, 36:2 267-282.
Khalil, A., Okasha, T., Shawky, M., Amany, H., Elhabiby, M., Carise, D., Annon, J., Hasson, A., and Rawson, R. (2008). Characterization of Substance Abuse Patients Presenting for Treatment at a University Psychiatric Hospital in Cairo, Egypt. Addictive Disorders & Their Treatment, 7, 199-209.
Anglin, M.D., Conner, B.T., Annon, J., & Longshore, D. (2007). Levo-alpha-acetylmethadol (LAAM) versus methadone maintenance: 1 –year treatment retention, outcomes and status. Addiction, 102(9), 1432-1442.
Ling, W., Amass, L., Shoptaw, S., Annon, J. Hillhouse, M., Babcock, D., Brigham, G., Harrer, J., Reid, M., Muir, J., Buchan, B., Orr, D., Woody, G., Krejci, J. and Ziedonis, D. (2005). A multi-center randomized trial of Buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction, 100, 1090-1100.
Longshore, D., Annon, J., Anglin, M., and Rawson, R (2005). Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use. Addiction, 100, 1131-1139.
Amass, L, Ling, W., Freese, T., Reiber, C., Annon, J., Cohen, A. et al. (2004) Bringing buprenorphine-naloxone detoxification to community treatment providers: The NIDA Clinical Trials Network field experience. American Journal on Addictions, 13, S42-S66.
Grella, C. E., Annon, J. J., & Anglin, M. D. (2000). Drug use and risk for HIV among women arrestees in California. AIDS and Behavior, 5(4) 289-295.
Carpenter, C. L., Longshore, D., Annon, K., Annon, J. J., & Anglin, M. D. (1999). Prevalence of HIV-1 among recent arrestees in Los Angeles County: Serial cross-sectional study, 1991 to 1995. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, in press.
Longshore, D., Annon, J., & Anglin, M. D. (1998). HIV prevalence among injection drug users in three Northern California communities. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 19(2), 200. (01.34)
Longshore, D., Annon, J., & Anglin, M. D. (1998). Long-Term Trends in Self-Reported HIV Risk Behavior: Injection Drug Users in Los Angeles, 1987 through 1995. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(1), 64-72.
Gil-Rivas, V., Anglin, M. D., & Annon, J. J. (1997). Patterns of drug use and criminal activities among Latino arrestees in California: Treatment and policy implications. Journal of Psychopathology and Behavioral Assessment, 19(2), 161-174.
Grella, C. E., Anglin, M. D., Wugalter, S. E., & Annon, J. J. (1997). The effectiveness of the Los Angeles enhanced methadone maintenance project: Reducing HIV risk among injection drug users. In F. M. Tims, J. A. Inciardi, B. W. Fletcher, & A. M. Horton (Eds.), The effectiveness of innovative approaches in the treatment of drug abuse (pp. 17-32). Westport, CT: Greenwood Press.
Grella, C.E., Anglin, M.D. and Annon, J.J. (1996). HIV Risk Behaviors Among Women in Methadone Maintenance Treatment. Substance Use and Misuse, 31(3), 277-301.
Grella, C.E., Annon, J.A. and Anglin, M.D. (1995). Ethnic Differences in HIV Risk Behaviors and Self-Perceptions Among Women in Methadone Maintenance Treatment. Journal of Psychoactive Drugs, 27(4), 319-343
Grella, C. E., Annon, J. J., & Anglin, M. D. (1995). Ethnic differences in HIV risk behaviors, self-perceptions, and treatment outcomes among women in methadone maintenance treatment. Journal of Psychoactive Drugs, 27(4), 421-433.
Last updated - 03/28/2016
Click here to view other profiles.